Concepedia

Michael P. Clark

MP

Statistics

Publications

37

Citations

1.8K

H-Index

25

Active since

1998

Affiliations

Procter & Gamble (United States)(Current)

Indiana University Bloomington

Vertex Pharmaceuticals (United States)

University College London

University of North Texas

Michael P. Clark is an author at Procter & Gamble (United States) specializing in medicinal chemistry, chemistry, and drug discovery.

ORCID

Publications per year

1998–2021

37

Publications

37

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 211 citations · Full text

, , +17

Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

Randal A. Byrn, Hamilton B. Bennett, Chris Bral et al. · Antimicrobial Agents and Chemotherapy · 2014 · 188 citations · Full text

, , +17

Development of Orally Bioavailable Bicyclic Pyrazolones as Inhibitors of Tumor Necrosis Factor-α Production

Michael P. Clark, Steven K. Laughlin, Matthew J. Laufersweiler et al. · Journal of Medicinal Chemistry · 2004 · 131 citations · Full text

, , +8

Enthalpy of Solvation Correlations for Gaseous Solutes Dissolved in Water and in 1-Octanol Based on the Abraham Model

Christina Mintz, Michael P. Clark, Michael H. Abraham · Journal of Chemical Information and Modeling · 2006 · 131 citations · Full text

, , +14

Total Synthesis of Phorboxazole A

David R. Williams, Andre A. Kiryanov, Ulrich Emde et al. · Angewandte Chemie International Edition · 2003 · 96 citations

, , +6

1–5 of 37